NEW YORK, Feb. 16, 2025 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Merck & Co., Inc. ("Merck" or "the Company") (NYSE: MRK) and certain of its officers.Class DefinitionThis lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Merck securities betwe ...

SAN DIEGO, Feb. 15, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period"), have until April 14, 2025 to seek appointment as lead plaintiff of the Merck class action lawsuit.  Captioned Cronin v. Merck & Co., Inc., No. 25-cv-01208 (D.N.J.), the Merck class action lawsuit charges Merck and certain of Merck's top executives with violations o ...

SAN DIEGO, Feb. 14, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025. Merck is a global healthcare company.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Investigating Allegations that Merck & Co., Inc. (MRK) Misled Investors Regarding ...

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2025.So what: If you purchased Merck securities during the Class Period you ma ...

Core Viewpoint - Buying dividend stocks at a cheap valuation can be advantageous, especially if the underlying business remains strong despite a price decline, allowing investors to benefit from higher yields and potential price rebounds [1]. Group 1: PepsiCo - PepsiCo's shares are currently at their lowest price since 2021, with a low price-to-earnings (P/E) ratio observed only a few times in the past five years [3]. - The company has faced slowing growth rates and consumer pushback against price hikes, leading to decreased investor enthusiasm [4]. - In Q4 2024, PepsiCo's revenue was $27.8 billion, nearly flat compared to Q4 2023, but profits increased by 16% to over $1.5 billion. The stock has declined approximately 14% over the past year, with a current dividend yield of 3.6% [5]. Group 2: United Parcel Service (UPS) - UPS shares dropped over 16% following earnings release and a strategic shift away from reliance on Amazon, which will reduce Amazon delivery volumes to less than half by the second half of 2026 [6]. - CEO Carol Tome indicated that this strategy may enhance overall profitability despite lower revenue, focusing on better margins rather than just sales growth [7]. - UPS projects $89 billion in revenue for the current year, down from $91.1 billion in 2024, but the stock offers a high yield of 4.9%, significantly above the S&P 500 average of 1.2% [8]. Group 3: Merck - Merck's current dividend yield is 3.3%, with shares trading at their lowest since late 2022 [9]. - The company has paused shipments of its Gardasil vaccine to China due to weak demand, raising concerns about future sales amid potential trade tensions [10]. - There are worries about significant sales declines for Merck's top-selling cancer drug, Keytruda, as biosimilars may enter the market as early as 2028 [11]. - Despite current challenges, Merck's stock is trading at less than 10 times estimated future earnings, making it a potentially attractive long-term investment [12]. - Investors are advised to remain patient with Merck, as it continues to work on new product developments [13].

SAN DIEGO, Feb. 13, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Merck & Co., Inc. (NYSE: MRK) securities between February 3, 2022 and February 3, 2025, inclusive (the "Class Period"), have until April 14, 2025 to seek appointment as lead plaintiff of the Merck class action lawsuit.  Captioned Cronin v. Merck & Co., Inc., No. 25-cv-01208 (D.N.J.), the Merck class action lawsuit charges Merck and certain of Merck's top executives with violati ...

Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare industry. Just last month, AWS and General Catalyst announced their partnership to speed up the development and deployment of healthcare AI tools. GE Healthcare teamed up with AWS to build generative AI for medical use in 2024.  Now, a Thailand-based healthcare startup, HD, has built a marketplace, HDmall, to digitize the fragmented medical industry in Southeast Asia. The startup helps user ...

We’re a father-and-son team dedicated to helping individual investors achieve financial independence through strategic dividend investing. With years of combined experience and a deep understanding of the markets, we’ve developed a straightforward yet powerful method that empowers investors like you to take control of your financial future, create a massive dividend snowball, and retire happy and free. At The Dividend Freedom Tribe, we don’t serve institutional clients or cater to Wall Street’s elite. Inste ...

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments.While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is the distribution of a company's earnings paid out to shareholders; it's often viewed by its ...

INDIA - 2025/01/28: In this photo illustration, a Merck logo is seen displayed on a smartphone with ... [+] an Artificial Intelligence (text) in the background. (Photo Illustration by Avishek Das/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images Merck (NYSE: MRK) recently released its Q4 results, with revenues and earnings exceeding the street estimates. The company reported revenue of $15.6 billion and adjusted earnings of $1.72 per share, compared to the consensus estimates ...